{"id":249637,"date":"2014-04-16T21:43:17","date_gmt":"2014-04-17T01:43:17","guid":{"rendered":"http:\/\/www.eugenesis.com\/celera-researchers-investigating-genetic-risk-signature-to-predict-atrial-fibrillation\/"},"modified":"2014-04-16T21:43:17","modified_gmt":"2014-04-17T01:43:17","slug":"celera-researchers-investigating-genetic-risk-signature-to-predict-atrial-fibrillation-2","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/genetic-engineering\/celera-researchers-investigating-genetic-risk-signature-to-predict-atrial-fibrillation-2.php","title":{"rendered":"Celera Researchers Investigating Genetic Risk Signature to Predict Atrial Fibrillation"},"content":{"rendered":"<p><p>    CollabRx has appointed Paul    Billings to its board of directors. Billings is a    board certified internist and clinical geneticist and most    recently served as chief medical officer for Life    Technologies. He is executive chairman of    Melanoma Diagnostics, a director of    Trovagene, and a co-founder and past medical    director of the Cordblood Registry. He was    also a senior vice president for corporate development at    Laboratory Corporation of America and a    co-founder of Omicia. Billings also currently    serves on the Scientific Advisory Board of the US Food    and Drug Administration, the Genomic Medicine Advisory    Committee at the Department of Veterans    Affairs, and the National Academy of Sciences    Institute of Medicines Roundtable on Genomics.  <\/p>\n<p>    Kathy Hibbs, former senior VP and general    counsel at Genomic Health, has joined    23andMe as chief legal and regulatory officer.    Hibbs joins 23andMe while the firm is in the midst of    regulatory discussions with the US Food and Drug Administration    regarding its Personal Genome Service. Hibbs has also worked at    Monogram Biosciences and Varian    Medical Systems, and is actively engaged in a number    of industry groups, such as the American Clinical    Laboratory Association, the Coalition for 21st    Century Medicine, and the Personalized    Medicine Coalition.  <\/p>\n<p>    Stephen Rusckowski has been named chairman of    the American Clinical Laboratory Association's    board of directors. Rusckowski has served as Quest    Diagnostics' president and CEO since May 2012. Before    joining Quest Diagnostics he was CEO of Philips    Healthcare.  <\/p>\n<p>    ProteinSimple has appointed Joe    Keegan and Chris van Ingen to its    board of directors. Keegan was previously the CEO of    ForteBio and Molecular    Devices. Van Ingen was previously president of    Agilent Technologies' bio-analytical    measurement business. He currently serves on the boards of    Bruker, Accelrys, and    Promega.  <\/p>\n<p><!-- Auto Generated --><\/p>\n<p>Read more:<br \/>\n<a target=\"_blank\" href=\"http:\/\/www.genomeweb.com\/clinical-genomics\/celera-researchers-investigating-genetic-risk-signature-predict-atrial-fibrillat\/RS=^ADA90X4uRiA300LDlTz_euxxDSWqUk-\" title=\"Celera Researchers Investigating Genetic Risk Signature to Predict Atrial Fibrillation\">Celera Researchers Investigating Genetic Risk Signature to Predict Atrial Fibrillation<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> CollabRx has appointed Paul Billings to its board of directors.  <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/genetic-engineering\/celera-researchers-investigating-genetic-risk-signature-to-predict-atrial-fibrillation-2.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":57,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[3],"tags":[],"class_list":["post-249637","post","type-post","status-publish","format-standard","hentry","category-genetic-engineering"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/249637"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/57"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=249637"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/249637\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=249637"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=249637"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=249637"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}